News

conference

Aug 29, 2021

2021 - ESMO - Preclinical Poster

Click Activated Protodrugs Against Cancer (CAPAC) Platform Enhances the Safety, Pharmacokinetics, and Antitumor Efficacy of Cancer Therapies in vivo

press

Apr 27, 2021

Press Release

Shasqi Awarded Prestigious Direct-to-Phase-2 Small Business Innovation Research Grant by National Cancer Institute

press

Apr 10, 2021

Press Release

Shasqi to Present Data on Novel Click Chemistry Platform at the American Association for Cancer Research (AACR) Annual Meeting

conference

Mar 25, 2021

2021 - AACR - Clinical Poster

First-in-human Phase I Study of SQ3370, a Click Activated Protodrug Therapy, in Patients with Advanced Solid Tumors

conference

Mar 25, 2021

2021 - AACR - Preclinical Poster

The CAPAC Platform Maximizes Therapeutic Benefit and Reduces Systemic Cytotoxic Exposure in Small and Large Animals

press

Feb 10, 2021

Press Release

Shasqi Announces Strategic Advisors as it Advances Click-Chemistry based Treatments for Cancer

press

Jan 27, 2021

Press Release

Shasqi Announces Publication of Preclinical Data Demonstrating Proof-of-Principle for Click-Activated Approach to Cancer Treatment

publication

Jan 20, 2021

Advanced Therapeutics

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions

conference

Jan 13, 2021

2021 - JPMHC Presentation

Shasqi's Click Activated Against Protodrugs

press

Jan 7, 2021

Press Release

Shasqi to Present at 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021

publication

Jan 5, 2021

Chemical Science

Click Activated Protodrugs Against Cancer Increase the Therapeutic Potential of Chemotherapy through Local Capture and Activation

press

Nov 20, 2020

Press Release

Shasqi Presents Preclinical and Trial-in-Progress Posters at CTOS 2020